Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)

NCT00455325 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome X
Overweight
Hypertension
Dyslipidemias
Prediabetic State

Interventions

DRUG: Placebo Comparator: First Intervention (3 weeks)
DRUG: Active Comparator: Second Intervention (3 weeks)
DRUG: Active Comparator: Third Intervention (3 weeks)
DRUG: Active Comparator: Fourth Intervention (3 weeks)

Sponsor

Washington University School of Medicine

Collaborators

[object Object]